跳至主要内容
临床试验/NCT03588000
NCT03588000已完成不适用

The Effect of Remote Self-monitoring of Blood Glucose (SMBG) Combined With the Promotion and Application of Internet Mobile Terminal (APP) on the Improvement of the Staged Type 2 Diabetes Mellitus (T2DM) Management and the Success Rate of Blood Glucose in the Community

Yuwen Zhang1 个研究点 分布在 1 个国家目标入组 498 人开始时间: 2018年11月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
498
试验地点
1
主要终点
absolute change in % HbA1c from baseline to 12 months

研究概览

简要总结

To investigate whether strengthen community diabetes patients self-monitoring of blood glucose can improve the patient's blood glucose control under Chinese guidelines for the prevention and treatment of diabetes (CDS 2017) and whether this intervention produces health and economic benefits.

详细描述

This project is a cohort intervention study for randomized controlled trials. Community health service centers are the main body of implementing treatment and community diabetes patients are the objects of intervention. 498 T2DM patients with poor blood glucose control (7%<HbA1c≤9.5%) from 4 different community health service centers will be randomized into two groups (strengthen group and control group). Strengthen self-monitoring of blood glucose by APP is the intervention and its duration is 12 months. Follow-up time of this study is 24 months (12 months after the intervention stopped). The diabetes treatment of patients from both groups follows Chinese guidelines (CDS 2017).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of type 2 Diabetes
  • Between 18 and 79 years old
  • 7.0%<HbA1c ≤ 9.5%
  • Routinely uses a smart phone
  • Capability of operating the designated APP
  • Long-time residents in Jiading District, Shanghai, China
  • Subordinated to Shanghai medical insurance
  • Contracted residents of community in Jiading District, Shanghai, China
  • Being cognitively able to participate
  • Provision of written informed consent

排除标准

  • Type 1 diabetes, gestational diabetes mellitus or other types of diabetes mellitus
  • Currently pregnant or contemplating pregnancy within the next 24 months
  • Lactating women
  • Was not able to insist until the end (24 months)
  • Cognitive impairment
  • Migrant population

结局指标

主要结局

absolute change in % HbA1c from baseline to 12 months

时间窗: baseline to 12 months

absolute change in glycemic control (% HbA1c) from baseline to 12 months

次要结局

  • change in blood glucose from baseline to 24 month(baseline to 24 months)
  • absolute change in % HbA1c from baseline to 6 months(baseline to 6 months)
  • absolute change in % HbA1c from baseline at 24 months(baseline to 24 months)
  • change in blood glucose from baseline to 6 month(baseline to 6 months)
  • change in blood glucose from baseline to 12 month(baseline to 12 months)

研究者

发起方
Yuwen Zhang
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Yuwen Zhang

Principal Investigator

Ruijin Hospital

研究点 (1)

Loading locations...

相似试验